Literature DB >> 1860471

Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.

P Omvik1, P Lund-Johansen.   

Abstract

The acute haemodynamic effect of carvedilol, a new non-selective beta-receptor blocker with vasodilating effect, was examined at rest supine and sitting and during 100 W bicycle exercise in 18 patients (mean age 44 years) with essential hypertension. Intra-arterial blood pressure and heart rate were recorded continuously. Cardiac output was measured by dye dilution (Cardiogreen). Two h after the first oral dose (12.5-25 mg) of carvedilol, blood pressure was reduced in all patients sitting at rest, from 176/110 to 153/101 mmHg (P less than 0.001), associated with a reduction in cardiac index (16%; P less than 0.001) while total peripheral resistance remained unchanged or was slightly reduced. When sitting up after 2 h supine rest two patients had hypotensive reactions (excessive blood pressure drop; cold, pale, sweating skin) which disappeared after lying down with elevation of the legs and light physical exercise. The fall in cardiac index was due to reduction both in heart rate (8%, P less than 0.001) and stroke index (9%; P less than 0.01). During exercise the reduction in cardiac output was less (6%; P less than 0.05) while a clear reduction (6%; P less than 0.01) was seen in total peripheral resistance. This acute haemodynamic response is different from that seen immediately after conventional beta-blockers when total peripheral resistance always increases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860471     DOI: 10.1093/eurheartj/12.6.736

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Long-term hemodynamic effects of antihypertensive treatment.

Authors:  P Lund-Johansen; P Omvik; J E Nordrehaug
Journal:  Clin Investig       Date:  1992

Review 2.  Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  C J Dunn; A P Lea; A J Wagstaff
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

Review 3.  Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D McTavish; D Campoli-Richards; E M Sorkin
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

4.  Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.

Authors:  P Omvik; P Lund-Johansen; H Haugland
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 5.  A risk-benefit assessment of carvedilol in the treatment of cardiovascular disorders.

Authors:  W J Louis; H Krum; E L Conway
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

Review 6.  Clinical pharmacokinetics and pharmacodynamics of carvedilol.

Authors:  T Morgan
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.